CA3178914A1 - Detecting a chromosome conformation as marker for fibrosis, e.g. scleroderma - Google Patents
Detecting a chromosome conformation as marker for fibrosis, e.g. scleroderma Download PDFInfo
- Publication number
- CA3178914A1 CA3178914A1 CA3178914A CA3178914A CA3178914A1 CA 3178914 A1 CA3178914 A1 CA 3178914A1 CA 3178914 A CA3178914 A CA 3178914A CA 3178914 A CA3178914 A CA 3178914A CA 3178914 A1 CA3178914 A1 CA 3178914A1
- Authority
- CA
- Canada
- Prior art keywords
- orf1
- chromosome
- markers
- ssc
- obd168
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2008269.9 | 2020-06-02 | ||
| GBGB2008269.9A GB202008269D0 (en) | 2020-06-02 | 2020-06-02 | Detecting a chromosome marker |
| PCT/GB2021/051356 WO2021245409A1 (en) | 2020-06-02 | 2021-06-02 | Detecting a chromosome conformation as marker for fibrosis, e.g. scleroderma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3178914A1 true CA3178914A1 (en) | 2021-12-09 |
Family
ID=71526294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3178914A Pending CA3178914A1 (en) | 2020-06-02 | 2021-06-02 | Detecting a chromosome conformation as marker for fibrosis, e.g. scleroderma |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230193390A1 (enExample) |
| EP (1) | EP4158066A1 (enExample) |
| JP (1) | JP2023528621A (enExample) |
| KR (1) | KR20230019939A (enExample) |
| CN (1) | CN116507740A (enExample) |
| AU (1) | AU2021283746B2 (enExample) |
| CA (1) | CA3178914A1 (enExample) |
| GB (2) | GB202008269D0 (enExample) |
| IL (1) | IL298266A (enExample) |
| TW (1) | TW202210635A (enExample) |
| WO (1) | WO2021245409A1 (enExample) |
| ZA (1) | ZA202212301B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202314402D0 (en) * | 2023-09-20 | 2023-11-01 | Oxford BioDynamics PLC | Chromosome detection assay |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003259877A (ja) * | 2002-03-11 | 2003-09-16 | Sumitomo Pharmaceut Co Ltd | 肝線維症疾患マーカーおよびその利用 |
| US7468249B2 (en) * | 2004-05-05 | 2008-12-23 | Biocept, Inc. | Detection of chromosomal disorders |
| WO2005111241A2 (en) * | 2004-05-07 | 2005-11-24 | Applera Corporation | Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof |
| AU2006264564B2 (en) * | 2005-07-04 | 2012-04-19 | Erasmus University Medical Center | Chromosome conformation capture-on-chip (4c) assay |
| CN108624668B (zh) * | 2013-02-01 | 2022-12-02 | 加利福尼亚大学董事会 | 用于基因组组装及单体型定相的方法 |
| JP2018527016A (ja) * | 2015-06-24 | 2018-09-20 | オックスフォード バイオダイナミックス リミテッド | 染色体相互作用の検出 |
| ES2971286T3 (es) * | 2016-12-01 | 2024-06-04 | Oxford BioDynamics PLC | Aplicación de interacciones cromosómicas epigenéticas en diagnóstico de cáncer |
| CN111511930B (zh) * | 2017-11-03 | 2024-11-22 | 牛津生物动力有限责任公司 | 通过染色体相互作用遗传调节免疫响应 |
| US20230054595A1 (en) * | 2019-12-18 | 2023-02-23 | The Children's Hospital Of Philadelphia | Novel druggable targets for the treatment of inflammatory diseases such as systemic lupus erythematosus (sle) and methods for diagnosis and treatment using the same |
-
2020
- 2020-06-02 GB GBGB2008269.9A patent/GB202008269D0/en not_active Ceased
-
2021
- 2021-05-31 TW TW110119717A patent/TW202210635A/zh unknown
- 2021-06-02 CN CN202180060427.9A patent/CN116507740A/zh active Pending
- 2021-06-02 IL IL298266A patent/IL298266A/en unknown
- 2021-06-02 WO PCT/GB2021/051356 patent/WO2021245409A1/en not_active Ceased
- 2021-06-02 GB GB2219352.8A patent/GB2611903B/en active Active
- 2021-06-02 US US18/000,243 patent/US20230193390A1/en active Pending
- 2021-06-02 AU AU2021283746A patent/AU2021283746B2/en active Active
- 2021-06-02 JP JP2022574303A patent/JP2023528621A/ja active Pending
- 2021-06-02 EP EP21737122.8A patent/EP4158066A1/en not_active Withdrawn
- 2021-06-02 CA CA3178914A patent/CA3178914A1/en active Pending
- 2021-06-02 KR KR1020237000132A patent/KR20230019939A/ko active Pending
-
2022
- 2022-11-10 ZA ZA2022/12301A patent/ZA202212301B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB202219352D0 (en) | 2023-02-01 |
| AU2021283746B2 (en) | 2023-06-15 |
| WO2021245409A1 (en) | 2021-12-09 |
| GB202008269D0 (en) | 2020-07-15 |
| US20230193390A1 (en) | 2023-06-22 |
| ZA202212301B (en) | 2023-07-26 |
| CN116507740A (zh) | 2023-07-28 |
| GB2611903B (en) | 2025-08-06 |
| TW202210635A (zh) | 2022-03-16 |
| AU2021283746A1 (en) | 2022-12-22 |
| EP4158066A1 (en) | 2023-04-05 |
| IL298266A (en) | 2023-01-01 |
| GB2611903A (en) | 2023-04-19 |
| JP2023528621A (ja) | 2023-07-05 |
| KR20230019939A (ko) | 2023-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7631400B2 (ja) | 遺伝子調節 | |
| US20200407790A1 (en) | Biomarker | |
| AU2021283746B2 (en) | Detecting a chromosome conformation as marker for fibrosis, e.g. scleroderma | |
| WO2022148957A1 (en) | Chromosome interactions | |
| AU2021360263B2 (en) | Disease marker | |
| JP2025108590A (ja) | 診断用染色体マーカー | |
| US20240132959A1 (en) | Chromosome Interaction Markers | |
| CN110225981B (zh) | 分型方法 | |
| WO2012078321A1 (en) | Phased genome sequencing | |
| HK40076364A (en) | Diagnostic chromosome marker | |
| WO2014071200A1 (en) | Beta blocker responder status assays and related materials and methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250523 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250523 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20250531 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT Effective date: 20250531 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250601 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250603 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20250821 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20250821 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250821 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250821 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250822 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260714 |